search
Back to results

GDS Muscle and Articulation Chain Treatment for Chronic LBP and Spinal Stenosis (GDS)

Primary Purpose

Low Back Pain, Recurrent, Degenerative Disc Disease

Status
Completed
Phase
Not Applicable
Locations
Norway
Study Type
Interventional
Intervention
Muscle and articulation chains GDS method
Sponsored by
The Hospital of Vestfold
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Low Back Pain, Recurrent focused on measuring Muscle and articulation chains GDS method, pilot RCT, Oswestry Disability Index

Eligibility Criteria

35 Years - 75 Years (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • Men and women, age 35-75 years, with cronic (>3 months) LBP, may have irradiation in legs.
  • Degenerative changes in the lumbar spine verified on MR.

Exclusion Criteria:

  • Severe psychiatric disorder.
  • Comorbidity that prevents the patient from performing exercises and gradually increasing general activity when the back /leg function gradually allows it.
  • Already had surgery with fixation of lumbar spine.
  • Being in process of assessing disability insurance or economic compenastion for Health reasons.
  • Pregnancy

Sites / Locations

  • Vestfold Hospital

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

No Intervention

Arm Label

Muscle and Articulation chains GDS method treatment

Control (treatment as usual)

Arm Description

Participants in the intervention Group are examined and treated according to the principles of "Muscle and Articulation Chains GDS Method". They receive GDS treatment individually, up to 8 sessions of 1 hour.

The Control Group receives standard treatment from their RGP/ doctor. Some are prescribed physiotherapy or chiropractor treatment, or they choose their own alternatives.

Outcomes

Primary Outcome Measures

Oswestry Disability Index
Measures activity limitations

Secondary Outcome Measures

Visual analogue scale (VAS)
Measures pain on a line 0-100
EQ-5D-5L
Health-related quality of life measurement tool
The Keele Start Back screening tool
Psychosocial screening profile measurement tool

Full Information

First Posted
June 2, 2020
Last Updated
August 24, 2021
Sponsor
The Hospital of Vestfold
Collaborators
Oslo Metropolitan University
search

1. Study Identification

Unique Protocol Identification Number
NCT04436003
Brief Title
GDS Muscle and Articulation Chain Treatment for Chronic LBP and Spinal Stenosis
Acronym
GDS
Official Title
Evaluation of "Muscle and Articulation Chains GDS Method" Treatment for Inoperable Low Back Pain Patients - a Randomised, Controlled Pilot Trial.
Study Type
Interventional

2. Study Status

Record Verification Date
August 2021
Overall Recruitment Status
Completed
Study Start Date
November 14, 2018 (Actual)
Primary Completion Date
October 3, 2020 (Actual)
Study Completion Date
October 3, 2020 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
The Hospital of Vestfold
Collaborators
Oslo Metropolitan University

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Our purpose is to conduct a pilot study to evaluate GDS muscle and articulation chain treatment for inoperable spine patients with degenerative changes in the lumbar spine, compared to "standard treatment" (any other chosen treatment). The pilot study will be conducted as a randomized controlled trial (RCT) to investigate feasibility and benefit of GDS muscle and articulation chain treatment on pain, function and quality of life. The pilot study will form the basis for a later full-scale randomized study and the following research questions will be addressed: To what extent were the criteria for inclusion in the study suitable? How did the recruitment procedure work? How did the participants experience GDS treatment? To what extent were the selected outcome measures suitable at the different evaluation moments, and which outcome measure tested in this pilot study would be most suitable as primary outcome measure in a full-scale study? (user experience will be included in the evaluation) How was the change in the primary outcome measure (Oswestry Disability Index)? What will be the estimated time for inclusion of the required number of participants in a full-scale study? (required sample size will be based on strength calculation /saving of the outcome target chosen as primary outcome measure for full scale study) The study is a pilot study with a randomized controlled design, with follow-up after 3-4 months. Thirty patients are recruited and receive baseline examination and respond to the questionnaires before randomization. The patients receive a questionnaire by mail 3-4 months after inclusion (after the treatment is completed for intervention group ). The pilot study will be one-way blinded.
Detailed Description
Design: randomized, controlled trial with intervention and control arm. Recruitment: Patients are recruited from those relegated from GPs in Vestfold to the spine surgeons at Vestfold Hospital (SIV) for assessment of surgery. Participants who qualify for the study will be contacted by the project staff member (Sidsel Lombardo) who will provide the information about the study. Participants who are interested in participating will be assessed in terms of the study's inclusion and exclusion criteria. If these are met, the participant will be explained what the study is based on in detail, both orally and in writing (appendix in REK application). The participant is then asked if he / she is still willing to participate. They will then undergo the baseline survey, fill in the forms and then sign the consent declaration. Afterwards they are randomized to GDS treatment or standard therapy. Participants have the opportunity to quit along the way without affecting their health care and regular treatment. Inclusion criteria Women and men aged between 35 to 75 years, with chronic (> 3 months) low back pain, with or without irradiation in legs. Degenerative changes in the lumbar spine verified on MR. Exclusion criteria Severe psychiatric disorder Comorbidity that prevents the patient from performing exercises and gradually increasing general activity when the back / leg function permits it. Already had surgery with fixation of the lumbar spine. Pregnancy Being in process of assessing disability insurance or economic compensation for health reasons. Randomization procedure: After baseline survey and answered questionnaire, participants will be randomized to intervention and control group using a data generated randomization sequence at a 1: 1 ratio. Statisticians at the Musculoskeletal Health Research Group (MUSKHealth.com) at OsloMet will assist with the randomization sequence. Blinding: In this study, one cannot blind the participants nor the treating physiotherapist for which treatment they are receiving. However, research staff who collect and process data at the 3-4 month follow-up will be blinded to who is randomized to the intervention and control groups, respectively. Intervention: The treatment group is examined and evaluated based on the principles of the "muscle and articulation chains GDS method", and receive until 8 treatments of one hour. They meet once a week in the beginning, more seldom towards the end of treatment. The participants pay for the individual treatments, but half prize of usual physiotherapy rate. The reason is that there is no extra money in SIV Hospital to provide free treatment, and that patients today pay regular rates for the same. Participants' follow-up to the intervention will be logged by the attending physiotherapist. The same applies to apostasy. Control: The control group receives standard treatment from their GP, possibly referred to physiotherapy, chiropractor or the treatment option they prefer. At baseline, imaging diagnostic findings regarding degenerative findings in the spine obtained from patient records will also be included. Data on function using Oswestry list f Data collection: Background variables such as age, gender, education level, marital status, mother tongue, height and weight will only be obtained at baseline (before randomization). The same applies to mapping the risk of chronic back pain, which will be mapped using the STarT Back screening form [12]. Imaging diagnostic regarding degenerative findings in the spine obtained from patient records will also be included. Functional data using the Oswestry list for functional limitations [10], pain using the VAS scale [8], health-related quality of life using the EQ-5D [11], risk for chronic back pain using the StarT Back screening form [12] and work ability will be obtained before and after intervention (3-4 months). A questionnaire at 3-4 months follow-up will be sent by mail, with a stamped envelope for return. Patients who do not respond will be reminded twice. Statistical analysis and sample size: This pilot study will also be used to make a strength calculation for a full-scale RCT. Nevertheless, if we use minimum clinical important difference (MCID) estimates in primary outcome measures as a starting point for a strength calculation, we will get the following reasoning: MCID for ODI has been found to be between 8 and 10 points on the scale from 0 to 10 [10]. Assuming an expected difference between two groups of 8 ODI points with a standard deviation (SD) of 10 and significance level of 5%, then we will have 80% strength to detect this difference with a sample of 50 people in each group. We account for 15% drop-out, ie a full-scale study will require 115 patients. If the pilot study proves to be able to expect greater differences in ODI scores between the groups, then this number could be reduced, and vice versa. For this pilot study, the aim is to include totally 30 participants for intervention and control groups.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Low Back Pain, Recurrent, Degenerative Disc Disease
Keywords
Muscle and articulation chains GDS method, pilot RCT, Oswestry Disability Index

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Patients are randomized into intervention or Control Group.
Masking
InvestigatorOutcomes Assessor
Masking Description
Investigator and outcome assessor will be masked for randomisation. It is not possible to mask the patient and treatment provider.
Allocation
Randomized
Enrollment
30 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Muscle and Articulation chains GDS method treatment
Arm Type
Experimental
Arm Description
Participants in the intervention Group are examined and treated according to the principles of "Muscle and Articulation Chains GDS Method". They receive GDS treatment individually, up to 8 sessions of 1 hour.
Arm Title
Control (treatment as usual)
Arm Type
No Intervention
Arm Description
The Control Group receives standard treatment from their RGP/ doctor. Some are prescribed physiotherapy or chiropractor treatment, or they choose their own alternatives.
Intervention Type
Behavioral
Intervention Name(s)
Muscle and articulation chains GDS method
Other Intervention Name(s)
Les Chaines Musculaires et Articulaires Methode GDS
Intervention Description
A physiotherapy method adapting treatment to patient's "terrain", or psychomorphology, using chosen techniques to balance tension between muscle chains, thus optimalizing posture and mouvement.
Primary Outcome Measure Information:
Title
Oswestry Disability Index
Description
Measures activity limitations
Time Frame
4 months
Secondary Outcome Measure Information:
Title
Visual analogue scale (VAS)
Description
Measures pain on a line 0-100
Time Frame
4 months
Title
EQ-5D-5L
Description
Health-related quality of life measurement tool
Time Frame
4 months
Title
The Keele Start Back screening tool
Description
Psychosocial screening profile measurement tool
Time Frame
4 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
35 Years
Maximum Age & Unit of Time
75 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Men and women, age 35-75 years, with cronic (>3 months) LBP, may have irradiation in legs. Degenerative changes in the lumbar spine verified on MR. Exclusion Criteria: Severe psychiatric disorder. Comorbidity that prevents the patient from performing exercises and gradually increasing general activity when the back /leg function gradually allows it. Already had surgery with fixation of lumbar spine. Being in process of assessing disability insurance or economic compenastion for Health reasons. Pregnancy
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Margreth Grotle, PhD
Organizational Affiliation
Oslo Metropolitan University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Vestfold Hospital
City
Larvik
ZIP/Postal Code
3257
Country
Norway

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
19564761
Citation
Diaz Arribas MJ, Ramos Sanchez M, Pardo Hervas P, Lopez Chicharro J, Angulo Carrere T, Ortega Molina P, Astasio Arbiza P. Effectiveness of the physical therapy Godelive Denys-Struyf method for nonspecific low back pain: primary care randomized control trial. Spine (Phila Pa 1976). 2009 Jul 1;34(15):1529-38. doi: 10.1097/BRS.0b013e3181aa2771.
Results Reference
result
Links:
URL
http://www.philippe-campignion.com
Description
home page of author of books about the method
URL
http://www.apgds.com
Description
association for practitioners

Learn more about this trial

GDS Muscle and Articulation Chain Treatment for Chronic LBP and Spinal Stenosis

We'll reach out to this number within 24 hrs